Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioEssays is Scopus-indexed (Q2, CiteScore 5.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 0265-9247Verify ISSN ↗1521-1878Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Cost to publish: About US$5,330 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 69 / 223 | 69th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present, best quartile Q2, CiteScore 5.4.
BioEssays is Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 69 of 223), by CiteScore 2025.
BioEssays is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.4, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.151, quartile Q1, with an H-index of 213.
The publisher lists an article processing charge of about US$5,330 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BioEssays is published by John Wiley & Sons Inc. Its print ISSN is 0265-9247 and its online ISSN is 1521-1878.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
BioEssays has an h-index of 257 and a 2-year mean of 4.04 citations per paper (OpenAlex). Its Scopus CiteScore is 5.4, quartile Q2. On 2-year citations it ranks #51 of 221 Scopus journals in Biochemistry, Genetics and Molecular Biology (all).
BioEssays published 140 papers in 2025; its busiest recent year was 2020 with 264. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from United States (38.2%), United Kingdom (7.8%) and Netherlands (7.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.